SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001349929-17-000002
Filing Date
2017-01-06
Accepted
2017-01-06 17:05:47
Documents
2
Period of Report
2017-01-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-010617.htm 8-K 29643
2 EXHIBIT 99.1 exhibit991-010617.htm EX-99.1 10064
  Complete submission text file 0001349929-17-000002.txt   41106
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 17514976
SIC: 8071 Services-Medical Laboratories